Paper17517839
Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.
Wolter DJ and 3 others. Antimicrob Agents Chemother, 2007. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin. Papers, record 17517839. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17517839
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Bacterial Proteins | Major topic |
| Ciprofloxacin | Major topic |
| Mutation | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Up-Regulation | Major topic |
| beta-Lactamases | Major topic |
| Gene Expression Regulation, Bacterial | |
| Humans | |
| Microbial Sensitivity Tests |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10681322 | Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10681322 | PubMed |
| 2 | 17015649 | Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. | J Bacteriol | 2006 | https://conductscience.org/library/papers/17015649 | PubMed |
| 3 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 4 | 12384343 | Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12384343 | PubMed |
| 5 | 12654751 | Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/12654751 | PubMed |
| 6 | 15380277 | Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. | Diagn Microbiol Infect Dis | 2004 | https://conductscience.org/library/papers/15380277 | PubMed |
| 7 | 3490520 | Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3490520 | PubMed |
| 8 | 3102630 | Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa. | J Infect Dis | 1987 | https://conductscience.org/library/papers/3102630 | PubMed |
| 9 | 3323160 | Induction of the SOS response by new 4-quinolones. | J Antimicrob Chemother | 1987 | https://conductscience.org/library/papers/3323160 | PubMed |
| 10 | 2513561 | Transformation of Pseudomonas aeruginosa by electroporation. | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2513561 | PubMed |
| 11 | 2158613 | Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. | Mutagenesis | 1990 | https://conductscience.org/library/papers/2158613 | PubMed |
| 12 | 1804005 | In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1804005 | PubMed |
| 13 | 8452351 | Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8452351 | PubMed |
| 14 | 7926843 | Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. | Gene | 1994 | https://conductscience.org/library/papers/7926843 | PubMed |
| 15 | 9174204 | Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174204 | PubMed |
| 16 | 10539994 | Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae. | Curr Pharm Des | 1999 | https://conductscience.org/library/papers/10539994 | PubMed |
| 17 | 9635237 | Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes. | Diagn Microbiol Infect Dis | 1998 | https://conductscience.org/library/papers/9635237 | PubMed |
| 18 | 9687387 | Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9687387 | PubMed |
| 19 | 9835532 | An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC beta-lactamase expression. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9835532 | PubMed |
| 20 | 10103195 | Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10103195 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32636831 | Mechanisms for Rapid Evolution of Carbapenem Resistance in a Clinical Isolate of Pseudomonas aeruginosa. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32636831 | PubMed |
| 28756823 | Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran. | J Epidemiol Glob Health | 2017 | https://conductscience.org/library/papers/28756823 | PubMed |
| 28182774 | Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs. | PLoS One | 2017 | https://conductscience.org/library/papers/28182774 | PubMed |
| 26729493 | Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26729493 | PubMed |
| 24409175 | Responses of Pseudomonas aeruginosa to antimicrobials. | Front Microbiol | 2014 | https://conductscience.org/library/papers/24409175 | PubMed |
| 19822890 | Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. | Clin Microbiol Rev | 2009 | https://conductscience.org/library/papers/19822890 | PubMed |
| 18779353 | Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18779353 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17517839
GET https://conductscience.org/api/papers/v1/17517839/references?page=2